| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.39 | 7e-10 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.35 | 9e-10 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.53 | 5e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.26 | 2e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.25 | 4e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |